Stock MLAB MESA LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Mesa Laboratories, Inc.

Equities

MLAB

US59064R1095

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX
Other stock markets
 12:22:10 2024-07-16 EDT 		5-day change 1st Jan Change
107.8 USD +4.88% Intraday chart for Mesa Laboratories, Inc. +16.12% +2.83%
07-08 Mesa Laboratories Maintains Quarterly Dividend at $0.16 a Share, Payable Sept. 16 to Holders of Record Aug. 30 MT
07-08 Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on September 16, 2024 CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Mesa Laboratories, Inc.

Mesa Laboratories Maintains Quarterly Dividend at $0.16 a Share, Payable Sept. 16 to Holders of Record Aug. 30 MT
Mesa Laboratories, Inc. Declares Quarterly Dividend, Payable on September 16, 2024 CI
Mesa Laboratories, Inc.(NasdaqGS:MLAB) added to Russell Small Cap Comp Value Index CI
Mesa Laboratories, Inc.(NasdaqGS:MLAB) added to Russell 2500 Value Index CI
Mesa Laboratories, Inc.(NasdaqGS:MLAB) added to Russell 3000 Value Index CI
Mesa Laboratories, Inc.(NasdaqGS:MLAB) added to Russell 2000 Value Index CI
Mesa Laboratories, Inc.(NasdaqGS:MLAB) added to Russell 2000 Value-Defensive Index CI
Mesa Laboratories, Inc.(NasdaqGS:MLAB) added to Russell 3000E Value Index CI
Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 Revenue $58.9M, vs. Street Est of $55.3M MT
Earnings Flash (MLAB) MESA LABORATORIES Posts Q4 EPS $2.77, vs. Street Est of $1.75 MT
Mesa Laboratories, Inc. Reports Impairment of Goodwill and Long-Lived Assets for the Fourth Quarter Ended March 31, 2024 CI
Mesa Laboratories, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 CI
Mesa Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
Mesa Laboratories, Inc. Delays Earnings Announcement for the Fourth Quarter and Full Fiscal Year 2024 Results CI
Mesa Laboratories, Inc. Amends and Restates Its Senior Secured Credit Agreement with Syndicate of Banks Led by JPMorgan Chase Bank, N.A CI
Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on June 14, 2024 CI
Mesa Laboratories, Inc. announced that it expects to receive $71.25 million in funding CI
Mesa Laboratories, Inc. Provides Impairment Guidance for the Fourth Quarter of 2024 CI
Earnings Flash (MLAB) MESA LABORATORIES Posts Q3 Revenue $53.5M MT
Earnings Flash (MLAB) MESA LABORATORIES Reports Q3 EPS $2.02 MT
Mesa Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Mesa Laboratories, Inc. Appoints Mark Capone to Its Board of Directors CI
Mesa Laboratories Maintains Quarterly Dividend at $0.16 a Share, Payable March 15 to Shareholders of Record as of Feb. 29 MT
Mesa Laboratories, Inc. Declares Regular Quarterly Dividend, Payable on March 15, 2024 CI
Evercore ISI Upgrades Mesa Laboratories to Outperform From In-Line, Raises Price Target to $125 From $100 MT

Chart Mesa Laboratories, Inc.

Chart Mesa Laboratories, Inc.
More charts

Company Profile

Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. It also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. It has manufacturing operations in the United States and Europe.
Sector
Medical Equipment, Supplies & Distribution
Calendar
2024-07-31 - Q1 2025 Earnings Release (Projected)
Related indices
Russell 2000
More about the company

Income Statement Evolution

More financial data

Ratings for Mesa Laboratories, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
102.8 USD
Average target price
118 USD
Spread / Average Target
+14.79%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
MESA LABORATORIES, INC. Stock Mesa Laboratories, Inc.
+2.83% 556M
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.56% 179B
MEDTRONIC PLC Stock Medtronic plc
-6.14% 98.84B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.61% 65.34B
HOYA CORPORATION Stock Hoya Corporation
+15.46% 45.41B
DEXCOM, INC. Stock DexCom, Inc.
-7.34% 44.94B
CENCORA, INC. Stock Cencora, Inc.
+9.71% 43.76B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+13.06% 29.01B
TERUMO CORPORATION Stock Terumo Corporation
+19.39% 25.65B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-7.01% 23.32B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. MLAB Stock
  4. News Mesa Laboratories, Inc.
  5. Mesa Laboratories Maintains Quarterly Dividend at $0.16 a Share, Payable Sept. 16 to Holders of Record Aug. 30